SCHEMBL28061397

SCHEMBL28061397

O=[C]NC1(CO)CCCC1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.37
MME P08473 1/20 0.32
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25282701 0.90
SCHEMBL2084465 0.80 DPP4 (0.41) DPP4
SCHEMBL8629131 0.74
SCHEMBL3667120 0.74 CYP2C19 (0.45) MME
SCHEMBL8630537 0.73 CETP (0.30)
SCHEMBL8625726 0.71 CETP (0.33)
SCHEMBL7409137 0.69 MEN1 (0.37)
SCHEMBL422018 0.67
SCHEMBL1488095 0.67
SCHEMBL16923652 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107158398-A The MetAP2 inhibitor and its treatment method of application of polymeric conjugation 辛德弗雷克斯公司 2017-09-15 CN disclosed
CN-107141410-A The MetAP2 inhibitor and its treatment method of application of polymeric conjugation 辛德弗雷克斯公司 2017-09-08 CN disclosed
CN-103140512-B Polymer-conjugated MetAP2 inhibitors and methods of treatment using the same 辛德弗雷克斯公司 2017-03-01 CN disclosed
CN-105431426-A METAP2 inhibitors and methods of treating obesity SYNDEVRX INC 2016-03-23 CN disclosed